FIELD: medicine, organic chemistry. SUBSTANCE: compounds having formula (I) 
where R1 is alkyl group, or groups having formula (II) 
, (III) 
, (IV) 
or (V) 
and R2, R3, R4 and R5 is hydrogen or various organic groups and their pharmaceutically acceptable salts are proposed for treatment and prophylaxis of hypercholesterolemia and atherosclerosis. EFFECT: improved quality of desired product. 33 cl, 32 dwg, 12 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDE DERIVATIVES, AND COMPOSITION HAVING ACAT-INHIBITING ACTIVITY | 1996 |
|
RU2128165C1 |
| PEPTIDE COMPOUNDS AND METHOD OF PREPARING THEREOF | 1993 |
|
RU2106357C1 |
| HEXAHYDRONAPHTHALENE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2104997C1 |
| AZASTEROIDAL COMPOUNDS | 1991 |
|
RU2070204C1 |
| α, ω-DIARYL ALKANES AND METHOD FOR THEIR PRODUCTION | 1993 |
|
RU2105752C1 |
| IMIDAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE ESTERS AND A METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2086541C1 |
| LIPID ANALOGS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2076107C1 |
| DERIVATIVES OF ISOXAZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2165415C2 |
| PIPERIDYLHYDROXY- OR QUINUCLIDINYLHYDROXY-ISOXAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION DECREASING COGNITIVE FUNCTION DISORDERS | 1993 |
|
RU2079496C1 |
| METHOD OF ISOXAZOLE DERIVATIVES SYNTHESIS | 1991 |
|
RU2017737C1 |
